E-mail a Wiley Online Library Link

Jiewen Zhu, Longen Zhou, Guikai Wu, Heiko Konig, Xiaoqin Lin, Guideng Li, Xiao-Long Qiu, Chi-Fen Chen, Chun-Mei Hu, Erin Goldblatt, Ravi Bhatia, A. Richard Chamberlin, Phang-Lang Chen and Wen-Hwa Lee A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia EMBO Molecular Medicine 5

Version of Record online: 22 JAN 2013 | DOI: 10.1002/emmm.201201760

Thumbnail image of graphical abstract

A newly identified RAD51 inhibitor leading to degradation of RAD51 via the proteasome pathway inhibits cancer cell survival and greatly increases life spans in a mouse chronic myeloid leukaemia model.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field